Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 6

Treatment of non-alcoholic fatty liver disease

Authors Keith G Tolman, Anthony S Dalpiaz

Published 15 January 2008 Volume 2007:3(6) Pages 1153—1163

Keith G Tolman1, Anthony S Dalpiaz2
1Division of Gastroenterology, Department of Internal Medicine, University of Utah School of Medicine; 2Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah, USA
Abstract: Non-alcoholic fatty liver disease, defined as the presence of macrovascular steatosis in the presence of less than 20 gm of alcohol ingestion per day, is the most common liver disease in the USA. It is most commonly associated with insulin resistance/type 2 diabetes mellitus and obesity. It is manifested by steatosis, steatohepatitis, cirrhosis, and, rarely, hepatocellular carcinoma.
Hepatic steatosis results from an imbalance between the uptake of fat and its oxidation and export. Insulin resistance, predisposing to lipolysis of peripheral fat with mobilization to and uptake of fatty acids by the liver, is the most consistent underlying pathogenic factor. It is not known why some patients progress to cirrhosis; however, the induction of CYP 2E1 with generation of reactive oxygen species appears to be important.
Treatment is directed at weight loss plus pharmacologic therapy targeted toward insulin resistance or dyslipidemia. Bariatric surgery has proved effective. While no pharmacologic therapy has been approved, emerging data on thiazolidinediones have demonstrated improvement in both liver enzymes and histology. There are fewer, but promising data, with statins which have been shown to be hepatoprotective in other liver diseases. The initial enthusiasm for ursodeoxycholic acid has not been supported by histologic studies.
Keywords: fatty liver, treatment

Download Article [PDF] 

Readers of this article also read:

Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy

Amreddy N, Muralidharan R, Babu A, Mehta M, Johnson EV, Zhao YD, Munshi A, Ramesh R

International Journal of Nanomedicine 2015, 10:6773-6788

Published Date: 29 October 2015

Improvement of fluvastatin bioavailability by loading on nanostructured lipid carriers

El-Helw AR, Fahmy UA

International Journal of Nanomedicine 2015, 10:5797-5804

Published Date: 16 September 2015

Effects of titania nanotubes with or without bovine serum albumin loaded on human gingival fibroblasts

Liu X, Zhou X, Li S, Lai R, Zhou Z, Zhang Y, Zhou L

International Journal of Nanomedicine 2014, 9:1185-1198

Published Date: 6 March 2014

Data quality of the monoclonal gammopathy of undetermined significance diagnosis in a hospital registry

Gregersen H, Larsen CB, Haglund A, Mortensen R, Andersen NF, Nørgaard M

Clinical Epidemiology 2013, 5:321-326

Published Date: 27 August 2013

MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice

Pan Y, Jia T, Zhang Y, Zhang K, Zhang R, Li J, Wang L

International Journal of Nanomedicine 2012, 7:5957-5967

Published Date: 3 December 2012

Visual acuity and visual skills in Malaysian children with learning disabilities

Muzaliha MN, Nurhamiza B, Hussein A, Norabibas AR, Mohd-Hisham-Basrun J, Sarimah A, Leo SW, Shatriah I

Clinical Ophthalmology 2012, 6:1527-1533

Published Date: 19 September 2012

Simple filter microchip for rapid separation of plasma and viruses from whole blood

Wang SQ, Sarenac D, Chen MH, Huang SH, Giguel FF, Kuritzkes DR, Demirci U

International Journal of Nanomedicine 2012, 7:5019-5028

Published Date: 17 September 2012

pH and temperature dual-sensitive liposome gel based on novel cleavable mPEG-Hz-CHEMS polymeric vaginal delivery system

Chen D, Sun K, Mu H, Tang M, Liang R, Wang A, Zhou S, Sun H, Zhao F, Yao J, Liu W

International Journal of Nanomedicine 2012, 7:2621-2630

Published Date: 28 May 2012

A review of rabeprazole in the treatment of acid-related diseases

Fabio Pace, Stefano Pallotta, Stefania Casalini, Gabriele Bianchi Porro

Therapeutics and Clinical Risk Management 2007, 3:363-379

Published Date: 15 July 2007

Mediterranean diet and prevention of coronary heart disease in the elderly

Anastasios S Dontas, Nicholas S Zerefos, Demosthenes B Panagiotakos, Dimitrios A Valis

Clinical Interventions in Aging 2007, 2:109-115

Published Date: 15 April 2007